CSAAI 2021 A Midsummer Night's Wheeze

June 25, 2021 to June 27, 2021

It is an exciting time in the field of allergy and immunology!  This CME/CEU program is designed to allow attendees to continue exploring the Immunology Frontier.  Covered topics include current and emerging treatments in atopic dermatitis, chronic rhinosinusitis with and without nasal polyps, translational targets for new asthma therapeutics, updates on immunodeficiencies, and oral desensitization to foods.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American College of Allergy, Asthma & Immunology (ACAAI) and the California Society of Allergy, Asthma and Immunology. The American College of Allergy, Asthma, and Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 12.75 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity

The American College of Allergy, Asthma & Immunology (ACAAI) is a provider, approved by the California Board of Registered Nursing, Provider Number CEP17239, for 12.75 contact hours.

Commercial Support
This activity is supported in part by independent medical education grant from Grifols, CSL Behring and Takeda.

Target Audience

Practicing allergists
Allied health professionals

Learning Objectives

Upon completion of this activity the participant should be able to:
- Discuss how phenotypes and endotypes influence choice of asthma therapeutics
- Identify some of the pitfalls, limitations, and knowledge gaps in atopic dermatitis. 
- Learn the links between infection and autoimmunity
- Learners will integrate treatment algorithm for CRSwNP

Additional information

As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all educational planners, presenters, instructors, moderators, authors, reviewers, and other individuals in a position to control or influence the content of an activity must disclose all relevant financial relationships with any commercial interest that have occurred within the past 12 months. All identified conflicts of interest must be resolved and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that disclosure be provided to the learners prior to the start of the activity. Individuals with no relevant financial relationships must also inform the learners that no relevant financial relationships exist. Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials. Disclosure in no way implies that the information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Moreover, expressed views do not necessarily reflect the opinions of the ACAAI.

Course summary
Available credit: 
  • 12.75 AMA PRA Category 1 Credit™
  • 12.75 Attendance
  • 12.75 CBRN
Course opens: 
Course expires: 
Event starts: 
06/25/2021 - 1:30pm CDT
Event ends: 
06/27/2021 - 12:30pm CDT

All identified conflicts of interest have been mitigated.

The individuals listed below disclose the following financial relationships:

Manish Butte, MD, PhD – Speaker
Speaker: CSL, Grifols
Principal Investigator: Regeneron, Horizon, Takeda, ADMA

Monica Kraft, MD – Speaker
Grant PI: AstraZeneca, Chiesi, Sanofi, ALA, NIH 
Independent Contractor: AstraZeneca, Sanofi
CMO: RaeSedo LLC

Peter A. Lio, MD – Speaker
Investigator: Regeneron/Sanofi Genzyme, AbbVie, AOBiome
Speaker: Regeneron/Sanofi Genzyme, Pfizer, L’Oreal, Galderma
Consultant: Regeneron/Sanofi Genzyme, AbbVie, AOBiome, LEO Pharma, Pfizer, Altus Labs, Micreos, Theraplex, Eli Lilly, L’Oreal, Galderma, Pierre-Fabre, Arbonne
Advisor: Altus Labs, Micreos, Theraplex
Advisory Board: Dermavant, Johnson & Johnson, Unilever, Bodewell, Burt’s Bees

Anna Nowak-Wegrzyn, MD, PhD – Speaker
Speaker: Nutricia, Nestle Nutrition Science
Author: Nutricia, Aimmune, UpToDate
Advisory Board: Novartis, Gerber Nutrition Institute
Data Monitoring Committee Member: Regeneron

David Stukus, MD – Speaker
Consultant: Before Brands Inc.
Author: Springer Publishing
Social Media Editor: American Academy of Allergy, Asthma and Immunology

James L. Sublett, MD, FACAAI – Speaker
Consultant: AllergyZone
Speaker/Teacher: GlaxoSmithKline

Arthur Wu, MD – Speaker
Speaker: Sanofi/Regeneron
Researcher: Gossamer Bio

Madeline Ramos, MD – Moderator, Planner
Owner (spouse): Actimatech

Raffi Tachdjian, MD – Planner
Speaker: Sanofi Regeneron, GSK, Takeda, CSL Behring, Pharming, Biocryst
Advisory Board: Sanofi Regeneron, Takeda, CSL Behring, Pharming, Biocryst

Sonal Patel, MD – Planner
Speaker: Sanofi Regeneron

Steven Meltzer, MD, MBA – Planner
Clinical Research: Pfizer, Regeneron, AstraZeneca, GSK

Barbara Ariue, MD – Planner
Consultant: Regeneron

The following have no relevant financial relationships to disclose:

Barbara Weissman, MD – Speaker
Shalin Pandya, DO – Speaker
J. Kevin Pedrotti – Speaker
Robert Eitches, MD – Planner
Marilyn Li, MD – Moderator, Planner, Reviewer 
LanAnh Do, MD – Planner
Vincent Tubiolo, MD – Planner 
Javed Sheikh, MD – Planner
Myngoc Nguyen, MD – Planner
Karol Anderson – Planner



Available Credit

  • 12.75 AMA PRA Category 1 Credit™
  • 12.75 Attendance
  • 12.75 CBRN
Please login or create an account to take this course.